Wall Street Column.

Publication: Wall Street Column (Steven Lord) (via Knight-Ridder/Tribune Business News)

Bookmark this article Print this article Link to this article Email this article Digg It! Add to del.icio.us RSS

COPYRIGHT 2004 Wall Street Column

Byline: Steven Lord

Nov. 15--STOCK TIPS FROM FINANCIAL NEWSLETTERS:

GROWTH STOCKS: "Pharmaceutical sales & marketing outsourcer Ventiv (VTIV) crushed Wall Street estimates of 16 cents per share for the third quarter, reporting 20 cents per share. This was up 67 percent over last year's EPS (earnings per share) from continuing operations. Revenues increased 50 percent to $89 million in the quarter. In response to this healthy report, Ventiv has taken its own 2004 EPS estimates up from the earlier range of 69 cents to 72 cents...

Read the full article for free courtesy of your local library.